← Back to Search

Behavioral Intervention

The BEET Diabetes Program for Eating Disorder

N/A
Waitlist Available
Led By Phoutdavone Phimphasone-Brady, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
T2DM diagnosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after completion of the 6 cbt sessions and 4-weeks after program completion (time differs by practice, up to 6 months)
Awards & highlights

Study Summary

This trial aims to test two programs that help people with type 2 diabetes who struggle with disordered eating behaviors. These behaviors, like binge eating or restrictive eating, can make it harder to manage diabetes

Who is the study for?
This trial is for individuals with type 2 diabetes who also struggle with disordered eating behaviors like binge or restrictive eating. It's designed to help them manage these behaviors as part of their diabetes treatment.Check my eligibility
What is being tested?
The study is testing two programs: Cognitive Behavioral Therapy Guided Self-Help and The BEET Diabetes Program, to see which might better assist in managing disordered eating in those with type 2 diabetes.See study design
What are the potential side effects?
Since the interventions are behavioral therapy programs, there may not be physical side effects like with medication. Participants could experience emotional discomfort addressing their eating habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 2 diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after completion of the 6 cbt sessions and 4-weeks after program completion (time differs by practice, up to 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after completion of the 6 cbt sessions and 4-weeks after program completion (time differs by practice, up to 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disordered Eating Behaviors (DEBs) - Change in Participant-Reported Outcomes (PROs)
Secondary outcome measures
Anxiety - Change in Participant-Reported Outcome (PROs)
Change in participant's HbA1c
Depression - Change in Participant-Reported Outcome (PROs)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: The BEET Diabetes ProgramExperimental Treatment1 Intervention
The BEET Diabetes program consists of 6 sessions that follow a sequence: the first 3-sessions weekly and the last 3-sessions every other week. These sessions help participants learn strategies and health behavior change through a self-monitoring form. Supporters (in this study, the BHPs) guide individuals through the program, maintain motivation, and facilitate appropriate goal-setting. The BEET Diabetes Program emphasizes treating disorder eating behaviors (DEBs) in the context of diabetes (i.e., psychoeducation on DEBs in diabetes, optimal daily glucose management, benefits of physical activity, and fruit and vegetable intake).
Group II: Cognitive behavioral Therapy Guided Self-helpActive Control1 Intervention
The Cognitive Behavioral Therapy Guided Self-help consists of 6 sessions that follow a sequence: the first 3-sessions weekly and the last 3-sessions every other week. These sessions help participants learn strategies and health behavior change through a self-monitoring form. The CBTgsh program is delivered through the self-help book: "Overcoming Binge Eating" by Christopher G. Fairburn. Guided support sessions can be provided by personnel with no background training or knowledge of CBT or DEBs, as the book acts as the "expert."

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,742 Previous Clinical Trials
2,152,679 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,364 Previous Clinical Trials
4,315,322 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,705 Previous Clinical Trials
7,507,206 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being accepted for enrollment in this clinical trial?

"According to clinicaltrials.gov, recruitment for this investigation is presently closed. The trial was introduced on January 5th, 2024 and last revised on February 6th, 2024. Despite its closure, there are currently 1148 ongoing trials that are actively enrolling participants."

Answered by AI

Are individuals older than 75 years being included in the patient recruitment for this study?

"To be considered for participation in this research, individuals aged between 18 and 65 are eligible. Notably, there are a total of 174 investigations targeting participants below the age of majority and 869 studies focusing on elderly patients above the age of sixty-five."

Answered by AI
~53 spots leftby Feb 2026